Journal ArticleOPEN ACCESS

The Herby Study: a Phase 2 Open-Label, Randomized, Multicenter Study of Bevacizumab-Based Therapy in Pediatric Patients with Newly Diagnosed High-Grade Glioma

  • Grill J
  • Hargrave D
  • Varlet P
  • et al.
Annals of Oncology (2014) 25 iv145
DOI: 10.1093/annonc/mdu330.27
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

46th Congress of The International Society of Paediatric Oncology (SIOP) 2014 Toronto, Canada, 22nd–25th October

Cite

CITATION STYLE

APA

Grill, J., Hargrave, D., Varlet, P., Jaspan, T., Jones, C., Massimino, M., … Vassal, G. (2014). The Herby Study: a Phase 2 Open-Label, Randomized, Multicenter Study of Bevacizumab-Based Therapy in Pediatric Patients with Newly Diagnosed High-Grade Glioma. Annals of Oncology, 25, iv145. https://doi.org/10.1093/annonc/mdu330.27

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free